17,23β-エポキシベラトラマン-3β-オール(4449-51-8)

ChemicalBook Optimization Suppliers
名前: Chembest Research Laboratories Limited  Gold
電話番号: 021-20908456
電子メール: sales@BioChemBest.com
名前: AdooQ Bioscience CHINA  Gold
電話番号: 025-58849295 18951903616;
電子メール: info@adooq.cn
名前: Nanjing Spring & Autumn Biological Engineering Co., Ltd.  Gold
電話番号: 025-84430028 13815430202
電子メール: sale02@cqherb.com
名前: Shanghai Winherb Medical Technology Co., Ltd.  Gold
電話番号: 400-186-5138 13341702378
電子メール: winherb@126.com
名前: Shanghai Boyle Chemical Co., Ltd.  
電話番号:
電子メール: sales@boylechem.com
17,23β-エポキシベラトラマン-3β-オール 製品概要
化学名:17,23β-エポキシベラトラマン-3β-オール
英語化学名:CYCLOPAMINE
别名:11-DEOXOJERVINE;CyclopaMine, froM VeratruM californiciM;CYCLOPAMINE;Spiro[9H-benzo[a]fluorene-9,2'(3'H)-furo[3,2-b]pyridin]-3-ol,1,2,3,3'a,4,4',5',6,6',6a,6b,7,7',7'a,8,11,11a,11b-octadecahydro-3',6',10,11b-tetraMethyl-,(2'R,3S,3'R,3'aS,6'S,6aS,6bS,7'aR,11aS,11bR)-;Cyclopamine 11-Deoxojervine (3b,23b)-17,23-Epoxy-11-deoxoveratraman-3-ol;Cyclopamine, >=98%;(3S,6AS,6bS,8aR,10S,12aS,13S,13aS,15aS,15bR)-10,13,14,15b-tetramethyl-1,2,3,4,6,6a,6b,7,7a,8a;11-DEOXYJERVINE
CAS番号:4449-51-8
分子式:C27H41NO2
分子量:411.62
EINECS:
カテゴリ情報:Inhibitors;antibiotic;Chiral Reagents;Intermediates & Fine Chemicals;Pharmaceuticals;Steroids;Lipid signaling
Mol File:4449-51-8.mol
17,23β-エポキシベラトラマン-3β-オール
17,23β-エポキシベラトラマン-3β-オール 物理性質
融点 236-238°C
沸点 531.29°C (rough estimate)
比重(密度) 1.0274 (rough estimate)
屈折率 1.6400 (estimate)
貯蔵温度 Keep in dark place,Inert atmosphere,Store in freezer, under -20°C
溶解性DMSO: soluble
外見 solid
酸解離定数(Pka)15.05±0.70(Predicted)
White
安定性:Store in Freezer at - 20°C
安全性情報
主な危険性 Xi
Sフレーズ 22-24/25
WGK Germany 3
RTECS 番号GY0750000
HSコード 29349990
有毒物質データの4449-51-8(Hazardous Substances Data)
MSDS Information
ProviderLanguage
SigmaAldrich English
17,23β-エポキシベラトラマン-3β-オール Usage And Synthesis
外観白色の粉末又は塊
溶解性エタノールに可溶(1mg/ml)。N,N-ジメチルホルムアミドに可溶(1 mg/ml)。
用途薬理作用研究用。
使用上の注意強い催奇性の疑いがありますので、取扱う場合は、保護眼鏡、保護手袋及び保護マスクを用いてください。
説明Cyclopamine is a natural steroidal alkaloid that inhibits signaling through the hedgehog pathway at the level of the pathway activator Smoothened. By altering gene expression in this signaling sequence, cyclopamine induces defects in morphogenesis, first observed in chicks and sheep as cyclopia. As a readout of action, cyclopamine inhibits hedgehog-dependent expression of Pax7 with an IC50 value of 24 nM. Although teratogenic during development, cyclopamine has potential applications in the treatment of cancer.
化学的特性White Crystalline Solid
使用Cyclopamine antibacterial properties. Cyclopamine demonstrates teratogenic properties and has been shown to reverse effects of oncogenic mutations in Smoothened and Patched.
使用Cyclopamine, is used as a hedgehog [Hh] signaling pathway and Smo inhibitor. It depletes stem-like cancer cells in glioblastoma and blocks tumor engraftment. Can also be used to induce differentiation of human embryonic stem cells (hESCs) into hormone-expressing endocrine cells.
使用Has antibacterial properties. Cyclopamine demonstrates teratogenic properties and has been shown to reverse effects of oncogenic mutations in Smoothened and Patched.1 Solubility: 1mg dissolves in 0.2ml DMSO with heating to approximately 70 degrees (ca. 12 mmol sol.) Solubility: 4mg dissolves in 1ml 95% Ethanol
定義ChEBI: Cyclopamine is a member of piperidines. It has a role as a glioma-associated oncogene inhibitor.
生物活性Inhibitor of hedgehog (Hh) signaling, likely via direct inhibition of Smoothened, the accessory protein to the putative Hh receptor Patched. Anti-cancer and teratogenic in vivo . Depletes stem-like cancer cells in glioblastoma and blocks tumor engraftment.
抗がん研究Cyclopamine is a natural compound that inhibits the Hedgehog signaling pathway.Cyclopamine targets Hedgehog by specifically hindering SMO activation.Cyclopamine therapy of murine medulloblastoma resulted in the inhibition ofproliferation, induction of neuronal differentiation, effective depletion of CSCs, andreduction of tumor burden in a mouse tumor allograft. Cyclopamine is effective inkilling of pancreatic, breast, and multiple myeloma CSCs. Cyclopamine incombination with gemcitabine inhibits metastatic spread and reduces primary tumorburden in pancreatic orthotopic xenografts. Mammosphere formation in breastcarcinoma and SC proliferation in multiple myeloma can be reduced by cyclopamine(Kawasaki et al. 2008). The HH ligand activation requires cholesterol at theircarboxyl ends, and 22-OH-cholesterol and 20-OH-cholesterol are reported toincrease the HH target gene expression, and this hypothesis of cholesterol-dependentHH signal transduction is investigated in M2-10B4 pluripotent mesenchymal stemcells. The mechanism underlying the positive regulation of HH signaling by theseoxidative species of cholesterol is not clear. However, this oxidative status ofcholesterol is altered by the endogenous ROS. Hence, the bioactive food componentsthat control the ROS levels can be important in regulating self-renewal and HHpathways (Kim et al. 2012). Cholecalciferol (vitamin D3, an isoform of vitamin D)is reported to be HH antagonist in vitro but not in vivo. Binding of cholecalciferol toSMO receptors results in the reduction of HH signaling in MDAMB231 andC3H/10 T1/2 fibroblast cells. 1 μM vitamin D3 shows more potent SMO inhibitoryaction than 10 μM cyclopamine in PTCH1-transfected C3H/10 T1/2 cells (Kimet al. 2012). Curcumin interferes with the Gli1 mRNA or Gli reporter activity andinhibits HH signaling in transgenic mouse prostate adenocarcinoma cells (Kimet al. 2012).
貯蔵+4°C
参考文献1) Watkins et al. (2003), Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer; Nature, 422 313
Tags:4449-51-8